评估重复接种流感疫苗参与者一年期抗体衰减的相关因素:一项六年队列研究
该研究纳入2016至2022年间多个季节(≥2季)接种标准剂量流感疫苗的330名参与者(584次观察),采用线性混合效应模型评估血凝抑制(HAI)综合评分下降速率(衰减评分)。结果显示,较高BMI与青少年亚组抗体下降更大幅度显著相关,而在成人或老年人中未见显著关联;各年龄组接种后较高滴度和较大接种前后提升评分与抗体衰减增加相关。研究结论强调年龄、BMI、接种史和免疫应答特征等多个因素影响重复接种后抗体衰减,并指出个性化接种策略对维持长期免疫的重要性。
要点
- 较高BMI与青少年亚组抗体下降更大幅度显著相关,成人或老年人中未见显著关联。
- 青少年中年龄与抗体衰减负相关,成人(19-64岁)中年龄与抗体衰减正相关。
- 各年龄组接种后较高滴度和较大接种前后提升评分与抗体衰减增加相关,青少年和成人中显著,老年人中不显著。
核心结论
- 该研究强调了年龄、BMI、接种史和免疫应答特征等多个因素影响重复接种流感疫苗后的抗体衰减。
- 研究结果强调个性化接种策略对维持长期免疫和增强疫苗效果的重要性。
研究设计与样本
- 该研究为六年队列研究,纳入2016至2022年间多个季节(≥2季)接种标准剂量流感疫苗的330名参与者(584次观察)。
- 前瞻性收集宿主人口学资料,每个季节接种前后采集血清样本。
- 采用限制性最大似然法(REML)的线性混合效应模型评估衰减评分,即血凝抑制(HAI)综合评分的下降速率,并校正人口学因素。
主要发现
- 较高BMI与青少年亚组抗体下降更大幅度显著相关,而在成人或老年人中未见显著关联。
- 青少年中年龄与抗体衰减负相关,成人(19-64岁)中年龄与抗体衰减正相关。
- 各年龄组接种后较高滴度和较大接种前后提升评分与抗体衰减增加相关,青少年和成人中效应显著,老年人中不显著。
- 研究流感季节的差异影响成人和总队列的抗体衰减,但在青少年或老年人(65岁及以上)中未见显著效应。
- 性别在任何年龄组中与抗体衰减均无显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term effects of host factors on vaccine-induced immune responses have been widely studied, but limited research has explored the waning of antibody levels after repeated influenza vaccinations in longitudinal settings. METHODS: This study included 330 participants (584 observations), who received the standard-dose influenza vaccine across multiple seasons (≥2) from 2016 to 2022. Host demographics were collected prospectively, and serum samples were obtained pre- and post-vaccination each season. Linear mixed-effects models using restricted maximum likelihood (REML) were applied to evaluate waning scores, defined as the rate of decline in hemagglutination inhibition (HAI) composite scores, while accounting for demographic factors. RESULTS: Higher BMI was significantly associated with greater antibody decline in the teenager subgroup, whereas no significant association was observed in adults or the elderly. In teenagers, age was negatively associated with antibody decline, whereas in adults (19-64 years), age was positively associated. Higher post-vaccination titers and greater pre-post vaccination boost scores were linked to increased antibody waning across all age groups, with significant effects observed in teenagers and adults but not the elderly. The differences by study influenza season influenced antibody waning in adults and the overall cohort but showed no significant effect in teenagers or the elderly (65+ years). Sex was not significantly associated with antibody waning in any age group. CONCLUSIONS: This study highlights multiple factors, including age, BMI, vaccination history, and immune response characteristics, that contribute to the waning of antibodies after repeated influenza vaccinations. These findings underscore the importance of personalized vaccination strategies to maintain long-term immunity and enhance vaccine effectiveness.
引用
- Cheng C, Chen X, Ge Y, et al. Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study. Vaccine. 2025. PMID: 41202613. doi:10.1016/j.vaccine.2025.127904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。